Literature DB >> 2522132

Immune deficiency in chronic Trypanosoma cruzi infection. Recombinant IL-1 restores Th function for antibody production.

S G Reed1, D L Pihl, K H Grabstein.   

Abstract

Mice with chronic Trypanosoma cruzi infections are unable to mount primary responses to T-dependent Ag, such as SRBC. Responses to SRBC were restored in vitro and in vivo with rIL-1. The cellular basis of the immunodeficiency and the mechanism of IL-1 action were investigated. B cells from infected mice were capable of normal levels of PFC production when provided with the appropriate signals, IL-2 plus IL-1. T cells from infected mice were unable to provide Th function to normal B cells. However, Th activity was provided by these cells if IL-1 was added to the cultures. Furthermore, T-depleted spleen cells from infected mice did not make antibody in the presence of normal T cells unless IL-1 was added to the cultures. Neutralizing antibody against IL-2 greatly reduced the augmentation by IL-1 of the antibody response of cells from infected mice. Together these results indicate that splenic B cells from infected mice are capable of antibody production, but that Th function is lacking in the spleens of infected mice. These results suggest that the inability of mice with T. cruzi infection to mount primary antibody responses to T-dependent Ag may be due to a macrophage defect lending to impairment of Th function. These results document the potential of IL-1 in restoring immune competence in an infectious disease model.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2522132

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase.

Authors:  C Hölscher; G Köhler; U Müller; H Mossmann; G A Schaub; F Brombacher
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Lymphoid hyperplasia in transgenic mice over-expressing a secreted form of the human interleukin-1beta gene product.

Authors:  O Björkdahl; P Akerblad; A Gjörloff-Wingren; T Leanderson; M Dohlsten
Journal:  Immunology       Date:  1999-01       Impact factor: 7.397

3.  Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells.

Authors:  B J Shenker; L A Vitale; D A Welham
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Interleukin-1-induced promotion of T-cell differentiation in mice immunized with killed Listeria monocytogenes.

Authors:  K Igarashi; M Mitsuyama; K Muramori; H Tsukada; K Nomoto
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

5.  Trypanosoma cruzi-induced immunosuppression: B cells undergo spontaneous apoptosis and lipopolysaccharide (LPS) arrests their proliferation during acute infection.

Authors:  E Zuñiga; C Motran; C L Montes; F L Diaz; J L Bocco; A Gruppi
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 6.  The Th1/Th2-like switch in syphilitic infection: is it detrimental?

Authors:  T J Fitzgerald
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

7.  Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution-partition analysis.

Authors:  M C Cerrone; D M Ritter; R E Kuhn
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Regulation of Trypanosoma cruzi infection in mice by gamma interferon and interleukin 10: role of NK cells.

Authors:  F Cardillo; J C Voltarelli; S G Reed; J S Silva
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

9.  Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning.

Authors:  M F Lopes; G A dos Reis
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

10.  Enhanced immunogenicity of a sequence derived from hepatitis B virus surface antigen in a composite peptide that includes the immunostimulatory region from human interleukin 1.

Authors:  K V Rao; A R Nayak
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.